SUPPLEMENTAL INFORMATION Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate to severe atopic dermatitis: results from the JADE REGIMEN phase 3 trial
收藏官方服务：
资源简介：
Supplemental material for Manuscript: Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate to severe atopic dermatitis: results from the JADE REGIMEN phase 3 trial (JAAD-D-21-00517R1)
创建时间：
2021-07-01
